While the COVID-19 pandemic has made clinical trials a much more common topic in the news over the last several months, the clinical research enterprise still has a way to […]
In response to the COVID-19 pandemic, researchers from the Massachusetts Institute of Technology (MIT) have published a pair of studies in a COVID-19 special issue of the Harvard Data Science Review, […]
During the pandemic, cancer patients undergoing treatment or participating in clinical trials at The University of Kansas Cancer Center (KU Cancer Center) don’t have to worry about whether they can […]
“Drug developers recognize the importance of participant demographic representation in the development of safe and effective medical treatments,” said Ken Getz, professor and deputy director of the Tufts Center for […]
As the clinical trial industry staggers through an epic pandemic called COVID-19, there’s been precious little time to think about planning for 2021 and beyond. However, with some states now […]